Literature DB >> 22271501

Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: a comparative analysis of three subgroups.

Chunyan Du1, Ye Zhou, Hong Cai, Guangfa Zhao, Hong Fu, Ying-Qiang Shi.   

Abstract

BACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the prognosis of stage I gastric cancer and to compare clinicopathologic characteristics by subgroup.
METHODS: Between January 2000 and December 2006, 384 patients with gastric cancer were reclassified as stage I according to the seventh edition classification. A comparative analysis was performed between three subgroups. Univariate and multivariate analyses were conducted.
RESULTS: The 5-year overall survival rates in T1N0, T1N1, and T2N0 were 98.8%, 94.1%, 91.1%, respectively (P = 0.009). In patients with T2N0 gastric cancer, tumors in the upper third and larger tumors were more common than in patients with T1N0 and T1N1 gastric cancer (P < 0.001). In patients with T1N1 and T2N0 gastric cancer, the presence of lymphatic and/or blood vessel invasion (LBVI) and perineural invasion (PNI) were more common than in patients with T1N0 gastric cancer (P < 0.001). Univariate analysis showed tumor stage, depth of invasion, LBVI, and PNI were significant prognostic factors. However, multivariate analysis demonstrated that only tumor stage, LBVI, and PNI were significant variables.
CONCLUSIONS: Survival data support the accuracy of new TNM classification for stage I gastric cancer. Tumor stage, the presence of LBVI and PNI are important independent prognostic factors in stage I gastric cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22271501     DOI: 10.1002/jso.22082

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

1.  Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.

Authors:  Sarah B Fisher; Sameer H Patel; David A Kooby; Sharon Weber; Mark Bloomston; Clifford Cho; Ioannis Hatzaras; Carl Schmidt; Emily Winslow; Charles A Staley; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2012-05-22       Impact factor: 3.647

2.  Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

3.  Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.

Authors:  Y Wang; J Zhang; S Guo; Z Dong; X Meng; G Zheng; D Yang; Z Zheng; Y Zhao
Journal:  Clin Transl Oncol       Date:  2019-03-22       Impact factor: 3.405

4.  Potential benefits of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy for cT1 upper-third gastric cancer.

Authors:  Kei Hosoda; Keishi Yamashita; Natsuya Katada; Hiromitsu Moriya; Hiroaki Mieno; Tomotaka Shibata; Shinichi Sakuramoto; Shiro Kikuchi; Masahiko Watanabe
Journal:  Surg Endosc       Date:  2015-10-28       Impact factor: 4.584

5.  Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.

Authors:  Chun-Yan Du; Jing-Gui Chen; Ye Zhou; Guang-Fa Zhao; Hong Fu; Xue-Ke Zhou; Ying-Qiang Shi
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

6.  Meta-analysis of the relationship between lymphovascular invasion and prognosis of patients with stage I gastric cancer.

Authors:  Dailong Li; Wanqiang Li; Yaqi Pang; Siqi Liu; Lu Xu; Xinhua Xu
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

7.  Predictive factors for recurrence in T2N0 and T3N0 gastric cancer patients.

Authors:  Hiroaki Saito; Yuki Murakami; Kozo Miyatani; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Langenbecks Arch Surg       Date:  2016-07-27       Impact factor: 3.445

8.  Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients.

Authors:  Jun Lu; Long-Long Cao; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Mi Lin; Ru-Hong Tu; Chang-Ming Huang; Chao-Hui Zheng
Journal:  Gastroenterol Res Pract       Date:  2018-07-11       Impact factor: 2.260

9.  Prognostic Nomogram for Early Gastric Cancer After Surgery to Assist Decision-Making for Treatment With Adjuvant Chemotherapy.

Authors:  Chao Zhang; Shutao Zhao; Xudong Wang
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

10.  Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?

Authors:  Hyun Beak Shin; Ji Yeong An; Seung Hyoung Lee; Yoon Young Choi; Jong Won Kim; Soo Sang Sohn; Sung Hoon Noh
Journal:  BMC Cancer       Date:  2017-04-22       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.